Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nutrastar International was a China-based consumer health company focused on premium branded Traditional Chinese Medicine, nutraceutical, and functional food products rather than a drug-development biotech pipeline. Its reported product portfolio included commercially cultivated Cordyceps militaris, functional health beverages, organic and specialty foods, and contract manufacturing-related activities in China. The company was incorporated in Nevada and traded publicly in the U.S. under the symbol NUIN, with operations centered in Harbin and Daqing, China. By 2016, the company disclosed investigations into its China operations and assets, and SEC filings indicated that operating entities had ceased operations amid financial disputes. It should therefore be treated as a defunct public consumer-health company, not an active clinical-stage biotech or pharma developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nutrastar International.